Islet Sciences Highlights Abstract at Arteriosclerosis, Thrombosis & Vascular Biology ATVB 2013
5/7/2013 8:16:13 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies for people with diabetes, announced today the acceptance and presentation of an abstract at the recent Arteriosclerosis, Thrombosis & Vascular Biology (ATVB) 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by